These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18711369)

  • 1. Report from Durham.
    Moul JW
    Prostate Cancer Prostatic Dis; 2008; 11(3):211. PubMed ID: 18711369
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk loci, biological candidates and biomarkers.
    Nat Genet; 2008 Mar; 40(3):257. PubMed ID: 18305468
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from Durham.
    Moul J
    Prostate Cancer Prostatic Dis; 2005; 8(1):1. PubMed ID: 15775990
    [No Abstract]   [Full Text] [Related]  

  • 4. Special report: recent developments in prostate cancer genetics and genetic testing.
    Technol Eval Cent Assess Program Exec Summ; 2009 Jan; 23(7):1-3. PubMed ID: 19297804
    [No Abstract]   [Full Text] [Related]  

  • 5. Five genetic variants associated with prostate cancer.
    Gartner CE; Barendregt JJ; Hall WD
    N Engl J Med; 2008 Jun; 358(25):2738-9; author reply 2741. PubMed ID: 18572445
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic gestalt.
    Kiser K
    Minn Med; 2005 Apr; 88(4):11-2. PubMed ID: 15940884
    [No Abstract]   [Full Text] [Related]  

  • 7. Inherited genetic markers and cancer outcomes: personalized medicine in the postgenome era.
    Rebbeck TR
    J Clin Oncol; 2006 May; 24(13):1972-4. PubMed ID: 16648495
    [No Abstract]   [Full Text] [Related]  

  • 8. Life insurance and genetic testing for prostate cancer: what advice for patients?
    Meyer JP; Westera J
    ANZ J Surg; 2012 Apr; 82(4):194-6. PubMed ID: 22510170
    [No Abstract]   [Full Text] [Related]  

  • 9. Five genetic variants associated with prostate cancer.
    Eisinger F
    N Engl J Med; 2008 Jun; 358(25):2740-1; author reply 2741. PubMed ID: 18572451
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic events highlight the challenge of validating prognostic biomarkers during the clinical and biologic evolution of prostate cancer.
    Febbo PG
    J Clin Oncol; 2009 Jul; 27(19):3088-90. PubMed ID: 19470924
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).
    Kirby RS; Fitzpatrick JM; Irani J
    BJU Int; 2009 Feb; 103(4):441-5. PubMed ID: 19154510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic predisposition to prostate cancer].
    Jeanteur P
    Bull Cancer; 2008 Nov; 95(11):1063-6. PubMed ID: 19036678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Opinion in Urology. Prostate cancer. Current world literature.
    Curr Opin Urol; 2009 May; 19(3):327-34. PubMed ID: 19363350
    [No Abstract]   [Full Text] [Related]  

  • 14. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical, laboratory and morphological features of prostatic precancer].
    Mazo EB; Meshkov VV
    Urologiia; 1999; (4):49-52. PubMed ID: 11149334
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic polymorphism and pathogenesis of benign prostatic hyperplasia.
    Konwar R; Chattopadhyay N; Bid HK
    BJU Int; 2008 Aug; 102(5):536-44. PubMed ID: 18410432
    [No Abstract]   [Full Text] [Related]  

  • 17. [Not Available].
    Aktuelle Urol; 2014 Nov; 45(6):430-1. PubMed ID: 25514770
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond PSA: utility of novel tumor markers in the setting of elevated PSA.
    Lin DW
    Urol Oncol; 2009; 27(3):315-21. PubMed ID: 19414121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Many unknowns in low-risk prostate cancer treatment. Ongoing studies and biomarker research may shed light on best approach.
    Printz C
    Cancer; 2009 Oct; 115(20):4645-6. PubMed ID: 19806595
    [No Abstract]   [Full Text] [Related]  

  • 20. Overview of Prostate Cancer Genetic Testing.
    Chandrasekar T; Kelly WK; Gomella LG
    Urol Clin North Am; 2021 Aug; 48(3):279-282. PubMed ID: 34210484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.